Intuitive Surgical raises FY23 procedure growth to up 18%-21% from 12%-16%

Sees FY23 gross profit margin 68%-69%. Sees FY23 operating expense growth 11%-15%.Sees FY23 tax rate 22%-24%. Says core business remains strong. Says saw surprising procedure strength in the quarter. Says U.S. performance was above trend. Says hospitals working through staffing restraints. Says expects to launch Ion in the UK as first entry into Europe. Says focused on increased adoption for procedures. Says pursuing expanded indications for new platforms. Says January and February were particularly strong. Says expects customers to be cautious in overall capital spending. Says operating expenses were moderately above expectations. Comments taken from Q1 earnings conference call.